Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Uncovering growth-suppressive MicroRNAs in lung cancer
Xi Liu, Lorenzo F Sempere, Fabrizio Galimberti, et al.
Research Square
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
Cell Communication and Signaling : CCS
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
The Journal of Clinical Investigation
|
March 19, 2010
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
Xi Liu, Lorenzo F Sempere, Haoxu Ouyang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models
Konstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
International Journal of Oncology
|
August 28, 2012
Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations
Fabrizio Galimberti, Alexander M Busch, Fadzai Chinyengetere, et al.
Molecular Cancer Therapeutics
|
May 21, 2013
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer
Tian Ma, Fabrizio Galimberti, Cherie P Erkmen, et al.
BMC Cancer
|
November 12, 2015
Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas
Fadzai Chinyengetere, David J Sekula, Yun Lu, et al.
Molecular Cancer Therapeutics
|
December 5, 2020
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
Masanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.
Molecular Cancer Research : MCR
|
March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
Lisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Uncovering growth-suppressive MicroRNAs in lung cancer
Xi Liu, Lorenzo F Sempere, Fabrizio Galimberti, et al.
Research Square
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
Cell Communication and Signaling : CCS
|
November 1, 2024
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish W Khan, Christine Powell, et al.
The Journal of Clinical Investigation
|
March 19, 2010
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
Xi Liu, Lorenzo F Sempere, Haoxu Ouyang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 4, 2011
Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models
Konstantin H Dragnev, Tian Ma, Jobin Cyrus, et al.
International Journal of Oncology
|
August 28, 2012
Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations
Fabrizio Galimberti, Alexander M Busch, Fadzai Chinyengetere, et al.
Molecular Cancer Therapeutics
|
May 21, 2013
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer
Tian Ma, Fabrizio Galimberti, Cherie P Erkmen, et al.
BMC Cancer
|
November 12, 2015
Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas
Fadzai Chinyengetere, David J Sekula, Yun Lu, et al.
Molecular Cancer Therapeutics
|
December 5, 2020
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
Masanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.
Molecular Cancer Research : MCR
|
March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
Lisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Page
of 8